Atrial fibrillation is the most commonly encountered, clinically significant arrhythmia. Dr Eli Gelfand discusses the key issues of atrial fibrillation management and takes a deep dive into the complexities and evidence that informs the pillars of atrial fibrillation management: anticoagulation, rate and rhythm control.
Introduction 0:00 Pathophysiology 1:24 Risk Factors 3:00 Atrial Fibrillation and Stroke Risk 6:18 Pillar One - Anticoagulation and CHADSVASC: 9:30 Direct Oral Anticoagulation: 18:30 Summary of Anticoagulation: 24:35 Pillar Two – Rate Control: 25:00 Pillar Three- Rhythm Control: 33:10 Atrial Fibrillation and Heart Failure: 41:00 Conclusion and Takeaways: 42:56
The Curbside Consults series complements the foundational information in NEJM R360 Rotation Prep by taking a deep dive into key clinical topics with expert clinicians and educators. These podcasts explore and critique the evidence behind clinical practice and break down statistical concepts for the busy clinical trainee.
Dr. Eli Gelfand is an Assistant Professor of Medicine at Harvard Medical School and the Section Chief of General Cardiology at Beth Israel Deaconess Medical Center (BIDMC). Dr. Gelfand is an active clinical cardiologist, who is involved in developing clinical applications of diagnostic imaging modalities, such as three-dimensional (3D) and intracardiac echocardiography (ICE) and cardiovascular magnetic resonance (CMR) imaging, with particular focus on imaging support of minimally-invasive therapies for valvular and congenital cardiac disease. He founded the Russian Cardiovascular and Latino Cardiovascular Clinics at BIDMC and has an active interest in Immigrant Health and Global Health issues. Concomitantly he serves as the Medical Director of Boston Symphony Hall.
Mike Mi is a 2017-2018 NEJM Editorial Fellow and a hospitalist at Beth Israel Deaconess Medical Center. He graduated from Harvard Medical School and completed his internal medicine training at BIDMC.